Welcome to our book review site www.go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Antimicrobial use and farm size in China’s Shandong province
In this paper, we examine antibiotic use in the Chinese hog farming sector. China warrants special atten-tion for several reasons. First, China is both the largest producer and the largest consumer of antibiotics in the world (Zhu et al. 2013). Second, it leads the world in use of antimicrobial drugs in livestock (Van Boeckel et al. 2015). Third, several studies have shown higher levels of antibiotic resistance in China than in other countries (Zhang et al. 2006; Hu et al. 2014; Hvistendahl 2012). Finally, the combination of high rates of antibiotic use and weak regulatory enforcement make China an ideal setting in which to examine the drivers of antimicrobial use in livestock production.
Microbial Biotechnology: Principles And Applications
Life science research and industry is developing rapidly all over the world. Microbial biotechnology is increasingly being regarded as a core subject in most university and polytechnic life science courses. There already exist a number of excellent general textbooks on microbiology and biotechnology that deal with the basic principles of the field. To complement them, this book focuses on the various applications of microbial-biotechnological principles. A teaching-based format is adopted, whereby working problems, as well as answers to frequently asked questions, supplement the main text. The book also includes real life examples of how the application of microbial-biotechnological principles has achieved breakthroughs in both research and industrial production.Although Microbial Biotechnology has been written for polytechnic students and undergraduates, it contains sufficient information to be used as a reference for postgraduate students and lecturers. It may also serve as a resource book for corporate planners, managers and applied research personnel.
Global Virology I - Identifying and Investigating Viral Diseases
This book provides trajectories and illustrations of viruses that have catapulted into the global arena (linked to humans, animals, and vectors) due to human behaviors in recent years, as well as viruses that have already shown expansion among humans, animals, and vectors just a few decades ago. Topics in the current book include: vaccines environmental impact emerging virus transmission Filovirus (Ebola) hemorrhagic fevers flaviviruses Dengue evasion papillomaviruses Hepatitis C Nipah virus giant viruses hantaviruses bunyaviruses encephalitides West Nile virus Zika virus XMRV henipaviruses human respiratory syncytial virus influenza A virus several aspects of HIV-1
Arresting Contagion
Sixty percent of infectious human diseases are shared with other vertebrates. Alan Olmstead and Paul Rhode tell how innovations to combat livestock infections—border control, food inspection, drug regulation, federal research labs—turned the U.S. into a world leader in combatting communicable diseases, and remain central to public health policy.
Diseases of Swine
A comprehensively updated edition of the gold standard reference on swine health and disease This newly revised Twelfth Edition of Diseases of Swine is designed to serve as a comprehensive and detailed reference on swine health and disease. It offers swine health specialists the information and knowledge they need to effectively respond to and treat pig diseases. It provides coverage of individual pig and herd health, making the book an effective resource for addressing diseases at the farm, local, regional, and global levels. With contributions and updates from more than 100 international experts in swine health, this edition of Diseases of Swine provides improved organization and ease of a...
Resistant Infections
Authors present differing opinions on whether resistant infections are a serious problem, whether drug-resistant infections are the result of the agricultural use of antibiotics, whether drug companies are at fault for not developing better antibacterial drugs, and how can the problems be remedied.
AASP Proceedings
None
